Skip to main content

Table 4 Effects of demographic characteristics on differences in the stigma for changes in SSCP scores

From: Scale development and an educational program to reduce the stigma of schizophrenia among community pharmacists: a randomized controlled trial

Characteristics

Educational lecture group

Contact-based intervention group

 

n = 56

n = 59

p

Gender

 Female

−2.0 (− 7.0–1.0)

−10.0 (− 21.0−− 7.0)

< 0.001

 Male

− 3.0 (−8.0–1.0)

− 8.0 (− 14.5−− 4.0)

0.008

Age

 20–29

−3.0 (− 7.0–0.0)

− 12.0 (− 21.0−− 7.0)

0.006

 30–39

− 2.0 (− 6.5–2.0)

− 9.0 (− 21.0−− 3.0)

0.007

 40–49

−6.0 (− 12.0–1.5)

−7.5 (− 9.3−− 4.0)

0.616

 50<

−3.0 (−7.0−− 2.0)

−13.0 (− 16.0−− 7.5)

0.071

Has visited a mental hospital

 positive

− 3.0 (− 4.5–2.5)

−8.0 (−15.5−− 4.5)

0.007

 negative

−3.0 (−8.0–1.0)

−9.0 (− 17.0−− 5.0)

< 0.001

Experience of mental illness via a family member or close friend

 positive

−1.5 (−6.5–2.3)

−9.0 (−17.0−−8.0)

0.001

 negative

−3.0 (−7.0–0.3)

−8.5 (−16.0−−4.0)

0.003

Experience of schizophrenia via a family member or close friend

 positive

1.0 (−7.0–3.0)

−8.0 (−13.0−−3.8)

0.10

 negative

−3.0 (−7.0–0.5)

−9.0 (−16.5−−5.0)

< 0.001

Psychiatric work experience

 positive

−2.0 (−6.5–0.0)

−9.0 (−16.0−−4.0)

0.024

 negative

−3.0 (−7.0–1.0)

−9.0 (−17.8−−5.3)

< 0.001

Frequency of medication counseling for schizophrenia patients

 Almost every day

–

–

–

 A few patients a week

−3.0 (−4.0–2.0)

−9.0 (−18.0–2.0)

0.26

 A few patients a month

−3.5 (−7.8–1.0)

−9.0 (−12.0−−4.0)

0.014

 A few patients a year

−2.5 (−10.0−−0.25)

−9.0 (− 21.0−−5.0)

0.035

 Nothing

−3.0 (−6.0–5.0)

−9.0 (−35.0−−7.0)

0.017

  1. The values in the table represent changes in the median (inter-quartile range) total SSCP score
  2. Statistical analysis was performed using the Mann-Whitney U test